Key Takeaways Rising sales in modern oral and hemp-based products, plus direct-to-consumer expansion, are fueling market share gains and revenue growth across new and premium categories. Shifts toward premium brands, operational efficiencies, and supply chain investments are strengthening profit margins and cash generation despite legacy segment headwinds.
